Valeant Offers to Buy Botox Maker Allergan

April 22 (Bloomberg) -- Valeant Pharmaceuticals International offered to buy Allergan for about $152.89 a share in a cash-and-stock deal that will give the Canadian company the Botox wrinkle treatment. Scarlet Fu reports on Bloomberg Television’s “Bloomberg Surveillance.” (Source: Bloomberg)

BHP Billiton Copper Output Misses Estimates
53:41 - BHP Billiton Ltd. cut its guidance for full-year copper output as much as 18 percent after a 44-day strike at the world’s biggest mine, adding to evidence output disruptions will hurt global supply. Bloomberg's Paul Allen reports on "Bloomberg Daybreak: Asia."   (Source: Bloomberg)
  • Why the Writers Guild of America May Go on Strike
  • Trump Team Pitches Tax Plan to Congress
  • China Merchants Bank Tackles Non-Performing Loans